SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 76 filers reported holding SCPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,548,607 | -30.1% | 1,200,647 | 0.0% | 2.46% | -19.3% |
| Q2 2023 | $12,234,593 | +12.3% | 1,200,647 | 0.0% | 3.05% | +9.4% |
| Q1 2023 | $10,889,868 | -44.5% | 1,200,647 | -56.1% | 2.78% | -47.2% |
| Q4 2022 | $19,608,889 | -9.8% | 2,734,852 | -18.0% | 5.27% | +26.5% |
| Q3 2022 | $21,743,000 | +26.7% | 3,334,852 | -6.4% | 4.17% | -1.9% |
| Q2 2022 | $17,166,000 | -21.1% | 3,561,474 | -7.0% | 4.25% | -10.7% |
| Q1 2022 | $21,763,000 | +13.1% | 3,831,474 | 0.0% | 4.75% | +31.7% |
| Q4 2021 | $19,234,000 | -24.5% | 3,831,474 | 0.0% | 3.61% | -30.2% |
| Q3 2021 | $25,479,000 | +8.8% | 3,831,474 | 0.0% | 5.17% | -12.2% |
| Q2 2021 | $23,410,000 | -8.1% | 3,831,474 | 0.0% | 5.89% | +28.4% |
| Q1 2021 | $25,479,000 | +25.7% | 3,831,474 | 0.0% | 4.59% | -32.8% |
| Q4 2020 | $20,268,000 | -29.0% | 3,831,474 | 0.0% | 6.83% | -9.1% |
| Q3 2020 | $28,544,000 | +1.2% | 3,831,474 | 0.0% | 7.51% | +21.5% |
| Q2 2020 | $28,200,000 | +17.1% | 3,831,474 | +17.8% | 6.18% | -17.1% |
| Q1 2020 | $24,075,000 | +30.7% | 3,253,440 | 0.0% | 7.45% | +88.1% |
| Q4 2019 | $18,414,000 | – | 3,253,440 | – | 3.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 2,051,805 | $20,907,893 | 8.53% |
| 5AM Venture Management, LLC | 1,200,647 | $12,234,593 | 3.05% |
| Worth Venture Partners, LLC | 512,337 | $5,220,714 | 2.84% |
| COWEN AND COMPANY, LLC | 1,837,918 | $18,728,384 | 1.55% |
| Orbimed Advisors | 5,559,528 | $56,651,590 | 1.03% |
| RTW INVESTMENTS, LP | 3,297,843 | $33,605,020 | 0.64% |
| EAM Investors, LLC | 265,528 | $2,705,730 | 0.50% |
| Rubric Capital Management LP | 811,517 | $8,269,358 | 0.35% |
| Ikarian Capital, LLC | 150,000 | $1,528,500 | 0.24% |
| Leucadia National | 831,000 | $8,467,890 | 0.08% |